ArticleERJ open research2019

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions.

Karlijn Hummelink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.